Biological E. COVID shot gets India emergency approval for 12-18 age group

Indian vaccine maker Biological E. Ltd said on Monday its COVID-19 vaccine received an emergency use approval in the country for use in children aged 12 to 18. The company's shot, called Corbevax, is the third vaccine approved for use in children aged 12 and above in India, joining Zydus Cadila's DNA shot ZyCoV-D and homegrown player Bharat Biotech's Covaxin. India has so far only started vaccinating children aged 15 and above. According to government figures, more than 76 million children between 15 and 17 have been inoculated mainly using Covaxin.